CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($)	Total	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit Prior to Exploration Stage [Member]	Accumulated Deficit During Exploration Stage [Member]
Balance at Dec. 31, 2017	$ (33,200,782)	$ 140,764	$ 71,152,311	$ (20,009,496)	$ (84,484,361)
Balance (in shares) at Dec. 31, 2017		140,763,549
Shares issued for directors fees and other services	60,000	$ 1,500	58,500	0	0
Shares issued for directors fees and other services (in shares)		1,500,000
Shares issued for warrant exercise	80,000	$ 2,000	78,000	0	0
Shares issued for warrant exercise (in shares)		2,000,000
Shares issued for private placement	1,735,000	$ 31,250	1,703,750	0	0
Shares issued for private placement (in shares)		31,250,000
Stock-based compensation expense	533,089	$ 0	533,089	0	0
Net Loss	(3,325,993)	0	0	0	(3,325,993)
Balance at Dec. 31, 2018	(34,118,686)	$ 175,514	73,525,650	(20,009,496)	(87,810,354)
Balance (in shares) at Dec. 31, 2018		175,513,549
Shares issued for directors fees and other services	223,903
Adoption of new accounting standards (Note 3) at Dec. 31, 2019	(4,941,447)	$ 0	0	0	(4,941,447)
Stock-based compensation expense	249,116	0	249,116	0	0
Net Loss	(5,973,132)	0	0	0	(5,973,132)
Balance at Dec. 31, 2019	$ (44,784,149)	$ 175,514	$ 73,774,766	$ (20,009,496)	$ (98,724,933)
Balance (in shares) at Dec. 31, 2019		175,513,549